注射用ヒト成長ホルモンのグローバル市場予測2023-2029

◆英語タイトル:Global Human Growth Hormone for Injection Market Growth 2023-2029

LP Informationが発行した調査報告書(LP23OT8959)◆商品コード:LP23OT8959
◆発行会社(リサーチ会社):LP Information
◆発行日:2023年10月
◆ページ数:104
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医薬品&ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「注射用ヒト成長ホルモンのグローバル市場」は、過去の販売実績から2022年の世界の注射用ヒト成長ホルモンの総販売量を検討し、2023年から2029年の予測される注射用ヒト成長ホルモンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の注射用ヒト成長ホルモンの市場規模を掲載し、XXX百万米ドル規模の世界の注射用ヒト成長ホルモン市場の詳細な分析を提供します。本インサイトレポートは、世界の注射用ヒト成長ホルモン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の注射用ヒト成長ホルモン市場における各社の独自のポジションをより深く理解するために、注射用ヒト成長ホルモン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の注射用ヒト成長ホルモン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。注射用ヒト成長ホルモンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。注射用ヒト成長ホルモンの中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。注射用ヒト成長ホルモンのヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

注射用ヒト成長ホルモンの世界主要メーカーとしては、Novo Nordisk、 LillyMedical、 Genentech、 Pfizer Medical、 Shanghai United Cell Biological Engineering、 EMD Serono, Inc.、 Cipla Ltd、 Roche Holding AG、 Anhui Anke Biotechnology (Group)、 Eli Lilly、 Ipsen、 LG Life Sciences、 Ferring Pharmaceuticals、 Teva Pharmaceutical Industriesなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の注射用ヒト成長ホルモン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査では注射用ヒト成長ホルモン市場をセグメンテーションし、種類別 (水射出式、粉体射出式)、用途別 (大人、子供)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:水射出式、粉体射出式

・用途別区分:大人、子供

・地域別区分
南北アメリカ(米国、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界の注射用ヒト成長ホルモン市場の10年間の市場状況・展望は?
・世界および地域別に見た注射用ヒト成長ホルモン市場成長の要因は何か?
・注射用ヒト成長ホルモンの市場機会はエンドマーケットの規模によってどのように変化するのか?
・注射用ヒト成長ホルモンのタイプ別、用途別の内訳は?
・新型コロナウイルスとロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:注射用ヒト成長ホルモンの年間販売量2018-2029、地域別現状・将来分析
・注射用ヒト成長ホルモンの種類別セグメント:水射出式、粉体射出式
・注射用ヒト成長ホルモンの種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・注射用ヒト成長ホルモンの用途別セグメント:大人、子供
・注射用ヒト成長ホルモンの用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の注射用ヒト成長ホルモン市場
・企業別のグローバル注射用ヒト成長ホルモン市場データ:2018-2023年の年間販売量、市場シェア
・企業別の注射用ヒト成長ホルモンの年間売上:2018-2023年の売上、市場シェア
・企業別の注射用ヒト成長ホルモン販売価格
・主要企業の注射用ヒト成長ホルモン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

注射用ヒト成長ホルモンの地域別レビュー
・地域別の注射用ヒト成長ホルモン市場規模2018-2023:年間販売量、売上
・主要国別の注射用ヒト成長ホルモン市場規模2018-2023:年間販売量、売上
・南北アメリカの注射用ヒト成長ホルモン販売の成長
・アジア太平洋の注射用ヒト成長ホルモン販売の成長
・ヨーロッパの注射用ヒト成長ホルモン販売の成長
・中東・アフリカの注射用ヒト成長ホルモン販売の成長

南北アメリカ市場
・南北アメリカの国別の注射用ヒト成長ホルモン販売量、売上(2018-2023)
・南北アメリカの注射用ヒト成長ホルモンの種類別販売量
・南北アメリカの注射用ヒト成長ホルモンの用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の注射用ヒト成長ホルモン販売量、売上(2018-2023)
・アジア太平洋の注射用ヒト成長ホルモンの種類別販売量
・アジア太平洋の注射用ヒト成長ホルモンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の注射用ヒト成長ホルモン販売量、売上(2018-2023)
・ヨーロッパの注射用ヒト成長ホルモンの種類別販売量
・ヨーロッパの注射用ヒト成長ホルモンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の注射用ヒト成長ホルモン販売量、売上(2018-2023)
・中東・アフリカの注射用ヒト成長ホルモンの種類別販売量
・中東・アフリカの注射用ヒト成長ホルモンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・注射用ヒト成長ホルモンの製造コスト構造分析
・注射用ヒト成長ホルモンの製造プロセス分析
・注射用ヒト成長ホルモンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・注射用ヒト成長ホルモンの主要なグローバル販売業者
・注射用ヒト成長ホルモンの主要なグローバル顧客

地域別の注射用ヒト成長ホルモン市場予測レビュー
・地域別の注射用ヒト成長ホルモン市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・注射用ヒト成長ホルモンの種類別市場規模予測
・注射用ヒト成長ホルモンの用途別市場規模予測

主要企業分析
Novo Nordisk、 LillyMedical、 Genentech、 Pfizer Medical、 Shanghai United Cell Biological Engineering、 EMD Serono, Inc.、 Cipla Ltd、 Roche Holding AG、 Anhui Anke Biotechnology (Group)、 Eli Lilly、 Ipsen、 LG Life Sciences、 Ferring Pharmaceuticals、 Teva Pharmaceutical Industries
・企業情報
・注射用ヒト成長ホルモン製品
・注射用ヒト成長ホルモン販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Growth Hormone for Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Human Growth Hormone for Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Human Growth Hormone for Injection by Country/Region, 2018, 2022 & 2029
2.2 Human Growth Hormone for Injection Segment by Type
2.2.1 Water Injection
2.2.2 Powder Injection
2.3 Human Growth Hormone for Injection Sales by Type
2.3.1 Global Human Growth Hormone for Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Human Growth Hormone for Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Human Growth Hormone for Injection Sale Price by Type (2018-2023)
2.4 Human Growth Hormone for Injection Segment by Application
2.4.1 Aldult
2.4.2 Child
2.5 Human Growth Hormone for Injection Sales by Application
2.5.1 Global Human Growth Hormone for Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Human Growth Hormone for Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Human Growth Hormone for Injection Sale Price by Application (2018-2023)
3 Global Human Growth Hormone for Injection by Company
3.1 Global Human Growth Hormone for Injection Breakdown Data by Company
3.1.1 Global Human Growth Hormone for Injection Annual Sales by Company (2018-2023)
3.1.2 Global Human Growth Hormone for Injection Sales Market Share by Company (2018-2023)
3.2 Global Human Growth Hormone for Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Human Growth Hormone for Injection Revenue by Company (2018-2023)
3.2.2 Global Human Growth Hormone for Injection Revenue Market Share by Company (2018-2023)
3.3 Global Human Growth Hormone for Injection Sale Price by Company
3.4 Key Manufacturers Human Growth Hormone for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Growth Hormone for Injection Product Location Distribution
3.4.2 Players Human Growth Hormone for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Growth Hormone for Injection by Geographic Region
4.1 World Historic Human Growth Hormone for Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Human Growth Hormone for Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Human Growth Hormone for Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Human Growth Hormone for Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Human Growth Hormone for Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Human Growth Hormone for Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Human Growth Hormone for Injection Sales Growth
4.4 APAC Human Growth Hormone for Injection Sales Growth
4.5 Europe Human Growth Hormone for Injection Sales Growth
4.6 Middle East & Africa Human Growth Hormone for Injection Sales Growth
5 Americas
5.1 Americas Human Growth Hormone for Injection Sales by Country
5.1.1 Americas Human Growth Hormone for Injection Sales by Country (2018-2023)
5.1.2 Americas Human Growth Hormone for Injection Revenue by Country (2018-2023)
5.2 Americas Human Growth Hormone for Injection Sales by Type
5.3 Americas Human Growth Hormone for Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Growth Hormone for Injection Sales by Region
6.1.1 APAC Human Growth Hormone for Injection Sales by Region (2018-2023)
6.1.2 APAC Human Growth Hormone for Injection Revenue by Region (2018-2023)
6.2 APAC Human Growth Hormone for Injection Sales by Type
6.3 APAC Human Growth Hormone for Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Growth Hormone for Injection by Country
7.1.1 Europe Human Growth Hormone for Injection Sales by Country (2018-2023)
7.1.2 Europe Human Growth Hormone for Injection Revenue by Country (2018-2023)
7.2 Europe Human Growth Hormone for Injection Sales by Type
7.3 Europe Human Growth Hormone for Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Growth Hormone for Injection by Country
8.1.1 Middle East & Africa Human Growth Hormone for Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Human Growth Hormone for Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Human Growth Hormone for Injection Sales by Type
8.3 Middle East & Africa Human Growth Hormone for Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Growth Hormone for Injection
10.3 Manufacturing Process Analysis of Human Growth Hormone for Injection
10.4 Industry Chain Structure of Human Growth Hormone for Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Growth Hormone for Injection Distributors
11.3 Human Growth Hormone for Injection Customer
12 World Forecast Review for Human Growth Hormone for Injection by Geographic Region
12.1 Global Human Growth Hormone for Injection Market Size Forecast by Region
12.1.1 Global Human Growth Hormone for Injection Forecast by Region (2024-2029)
12.1.2 Global Human Growth Hormone for Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Growth Hormone for Injection Forecast by Type
12.7 Global Human Growth Hormone for Injection Forecast by Application
13 Key Players Analysis
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Human Growth Hormone for Injection Product Portfolios and Specifications
13.1.3 Novo Nordisk Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 LillyMedical
13.2.1 LillyMedical Company Information
13.2.2 LillyMedical Human Growth Hormone for Injection Product Portfolios and Specifications
13.2.3 LillyMedical Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 LillyMedical Main Business Overview
13.2.5 LillyMedical Latest Developments
13.3 Genentech
13.3.1 Genentech Company Information
13.3.2 Genentech Human Growth Hormone for Injection Product Portfolios and Specifications
13.3.3 Genentech Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Genentech Main Business Overview
13.3.5 Genentech Latest Developments
13.4 Pfizer Medical
13.4.1 Pfizer Medical Company Information
13.4.2 Pfizer Medical Human Growth Hormone for Injection Product Portfolios and Specifications
13.4.3 Pfizer Medical Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Medical Main Business Overview
13.4.5 Pfizer Medical Latest Developments
13.5 Shanghai United Cell Biological Engineering
13.5.1 Shanghai United Cell Biological Engineering Company Information
13.5.2 Shanghai United Cell Biological Engineering Human Growth Hormone for Injection Product Portfolios and Specifications
13.5.3 Shanghai United Cell Biological Engineering Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Shanghai United Cell Biological Engineering Main Business Overview
13.5.5 Shanghai United Cell Biological Engineering Latest Developments
13.6 EMD Serono, Inc.
13.6.1 EMD Serono, Inc. Company Information
13.6.2 EMD Serono, Inc. Human Growth Hormone for Injection Product Portfolios and Specifications
13.6.3 EMD Serono, Inc. Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 EMD Serono, Inc. Main Business Overview
13.6.5 EMD Serono, Inc. Latest Developments
13.7 Cipla Ltd
13.7.1 Cipla Ltd Company Information
13.7.2 Cipla Ltd Human Growth Hormone for Injection Product Portfolios and Specifications
13.7.3 Cipla Ltd Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Cipla Ltd Main Business Overview
13.7.5 Cipla Ltd Latest Developments
13.8 Roche Holding AG
13.8.1 Roche Holding AG Company Information
13.8.2 Roche Holding AG Human Growth Hormone for Injection Product Portfolios and Specifications
13.8.3 Roche Holding AG Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Roche Holding AG Main Business Overview
13.8.5 Roche Holding AG Latest Developments
13.9 Anhui Anke Biotechnology (Group)
13.9.1 Anhui Anke Biotechnology (Group) Company Information
13.9.2 Anhui Anke Biotechnology (Group) Human Growth Hormone for Injection Product Portfolios and Specifications
13.9.3 Anhui Anke Biotechnology (Group) Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Anhui Anke Biotechnology (Group) Main Business Overview
13.9.5 Anhui Anke Biotechnology (Group) Latest Developments
13.10 Eli Lilly
13.10.1 Eli Lilly Company Information
13.10.2 Eli Lilly Human Growth Hormone for Injection Product Portfolios and Specifications
13.10.3 Eli Lilly Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Eli Lilly Main Business Overview
13.10.5 Eli Lilly Latest Developments
13.11 Ipsen
13.11.1 Ipsen Company Information
13.11.2 Ipsen Human Growth Hormone for Injection Product Portfolios and Specifications
13.11.3 Ipsen Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Ipsen Main Business Overview
13.11.5 Ipsen Latest Developments
13.12 LG Life Sciences
13.12.1 LG Life Sciences Company Information
13.12.2 LG Life Sciences Human Growth Hormone for Injection Product Portfolios and Specifications
13.12.3 LG Life Sciences Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 LG Life Sciences Main Business Overview
13.12.5 LG Life Sciences Latest Developments
13.13 Ferring Pharmaceuticals
13.13.1 Ferring Pharmaceuticals Company Information
13.13.2 Ferring Pharmaceuticals Human Growth Hormone for Injection Product Portfolios and Specifications
13.13.3 Ferring Pharmaceuticals Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Ferring Pharmaceuticals Main Business Overview
13.13.5 Ferring Pharmaceuticals Latest Developments
13.14 Teva Pharmaceutical Industries
13.14.1 Teva Pharmaceutical Industries Company Information
13.14.2 Teva Pharmaceutical Industries Human Growth Hormone for Injection Product Portfolios and Specifications
13.14.3 Teva Pharmaceutical Industries Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Teva Pharmaceutical Industries Main Business Overview
13.14.5 Teva Pharmaceutical Industries Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Human Growth Hormone for Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Human Growth Hormone for Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Water Injection
Table 4. Major Players of Powder Injection
Table 5. Global Human Growth Hormone for Injection Sales by Type (2018-2023) & (K Units)
Table 6. Global Human Growth Hormone for Injection Sales Market Share by Type (2018-2023)
Table 7. Global Human Growth Hormone for Injection Revenue by Type (2018-2023) & ($ million)
Table 8. Global Human Growth Hormone for Injection Revenue Market Share by Type (2018-2023)
Table 9. Global Human Growth Hormone for Injection Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Human Growth Hormone for Injection Sales by Application (2018-2023) & (K Units)
Table 11. Global Human Growth Hormone for Injection Sales Market Share by Application (2018-2023)
Table 12. Global Human Growth Hormone for Injection Revenue by Application (2018-2023)
Table 13. Global Human Growth Hormone for Injection Revenue Market Share by Application (2018-2023)
Table 14. Global Human Growth Hormone for Injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Human Growth Hormone for Injection Sales by Company (2018-2023) & (K Units)
Table 16. Global Human Growth Hormone for Injection Sales Market Share by Company (2018-2023)
Table 17. Global Human Growth Hormone for Injection Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Human Growth Hormone for Injection Revenue Market Share by Company (2018-2023)
Table 19. Global Human Growth Hormone for Injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Human Growth Hormone for Injection Producing Area Distribution and Sales Area
Table 21. Players Human Growth Hormone for Injection Products Offered
Table 22. Human Growth Hormone for Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Human Growth Hormone for Injection Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Human Growth Hormone for Injection Sales Market Share Geographic Region (2018-2023)
Table 27. Global Human Growth Hormone for Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Human Growth Hormone for Injection Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Human Growth Hormone for Injection Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Human Growth Hormone for Injection Sales Market Share by Country/Region (2018-2023)
Table 31. Global Human Growth Hormone for Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Human Growth Hormone for Injection Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Human Growth Hormone for Injection Sales by Country (2018-2023) & (K Units)
Table 34. Americas Human Growth Hormone for Injection Sales Market Share by Country (2018-2023)
Table 35. Americas Human Growth Hormone for Injection Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Human Growth Hormone for Injection Revenue Market Share by Country (2018-2023)
Table 37. Americas Human Growth Hormone for Injection Sales by Type (2018-2023) & (K Units)
Table 38. Americas Human Growth Hormone for Injection Sales by Application (2018-2023) & (K Units)
Table 39. APAC Human Growth Hormone for Injection Sales by Region (2018-2023) & (K Units)
Table 40. APAC Human Growth Hormone for Injection Sales Market Share by Region (2018-2023)
Table 41. APAC Human Growth Hormone for Injection Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Human Growth Hormone for Injection Revenue Market Share by Region (2018-2023)
Table 43. APAC Human Growth Hormone for Injection Sales by Type (2018-2023) & (K Units)
Table 44. APAC Human Growth Hormone for Injection Sales by Application (2018-2023) & (K Units)
Table 45. Europe Human Growth Hormone for Injection Sales by Country (2018-2023) & (K Units)
Table 46. Europe Human Growth Hormone for Injection Sales Market Share by Country (2018-2023)
Table 47. Europe Human Growth Hormone for Injection Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Human Growth Hormone for Injection Revenue Market Share by Country (2018-2023)
Table 49. Europe Human Growth Hormone for Injection Sales by Type (2018-2023) & (K Units)
Table 50. Europe Human Growth Hormone for Injection Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Human Growth Hormone for Injection Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Human Growth Hormone for Injection Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Human Growth Hormone for Injection Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Human Growth Hormone for Injection Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Human Growth Hormone for Injection Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Human Growth Hormone for Injection Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Human Growth Hormone for Injection
Table 58. Key Market Challenges & Risks of Human Growth Hormone for Injection
Table 59. Key Industry Trends of Human Growth Hormone for Injection
Table 60. Human Growth Hormone for Injection Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Human Growth Hormone for Injection Distributors List
Table 63. Human Growth Hormone for Injection Customer List
Table 64. Global Human Growth Hormone for Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Human Growth Hormone for Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Human Growth Hormone for Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Human Growth Hormone for Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Human Growth Hormone for Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Human Growth Hormone for Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Human Growth Hormone for Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Human Growth Hormone for Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Human Growth Hormone for Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Human Growth Hormone for Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Human Growth Hormone for Injection Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Human Growth Hormone for Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Human Growth Hormone for Injection Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Human Growth Hormone for Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Novo Nordisk Basic Information, Human Growth Hormone for Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Novo Nordisk Human Growth Hormone for Injection Product Portfolios and Specifications
Table 80. Novo Nordisk Human Growth Hormone for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Novo Nordisk Main Business
Table 82. Novo Nordisk Latest Developments
Table 83. LillyMedical Basic Information, Human Growth Hormone for Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. LillyMedical Human Growth Hormone for Injection Product Portfolios and Specifications
Table 85. LillyMedical Human Growth Hormone for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. LillyMedical Main Business
Table 87. LillyMedical Latest Developments
Table 88. Genentech Basic Information, Human Growth Hormone for Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Genentech Human Growth Hormone for Injection Product Portfolios and Specifications
Table 90. Genentech Human Growth Hormone for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Genentech Main Business
Table 92. Genentech Latest Developments
Table 93. Pfizer Medical Basic Information, Human Growth Hormone for Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Medical Human Growth Hormone for Injection Product Portfolios and Specifications
Table 95. Pfizer Medical Human Growth Hormone for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Pfizer Medical Main Business
Table 97. Pfizer Medical Latest Developments
Table 98. Shanghai United Cell Biological Engineering Basic Information, Human Growth Hormone for Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Shanghai United Cell Biological Engineering Human Growth Hormone for Injection Product Portfolios and Specifications
Table 100. Shanghai United Cell Biological Engineering Human Growth Hormone for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Shanghai United Cell Biological Engineering Main Business
Table 102. Shanghai United Cell Biological Engineering Latest Developments
Table 103. EMD Serono, Inc. Basic Information, Human Growth Hormone for Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. EMD Serono, Inc. Human Growth Hormone for Injection Product Portfolios and Specifications
Table 105. EMD Serono, Inc. Human Growth Hormone for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. EMD Serono, Inc. Main Business
Table 107. EMD Serono, Inc. Latest Developments
Table 108. Cipla Ltd Basic Information, Human Growth Hormone for Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Cipla Ltd Human Growth Hormone for Injection Product Portfolios and Specifications
Table 110. Cipla Ltd Human Growth Hormone for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Cipla Ltd Main Business
Table 112. Cipla Ltd Latest Developments
Table 113. Roche Holding AG Basic Information, Human Growth Hormone for Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Roche Holding AG Human Growth Hormone for Injection Product Portfolios and Specifications
Table 115. Roche Holding AG Human Growth Hormone for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Roche Holding AG Main Business
Table 117. Roche Holding AG Latest Developments
Table 118. Anhui Anke Biotechnology (Group) Basic Information, Human Growth Hormone for Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Anhui Anke Biotechnology (Group) Human Growth Hormone for Injection Product Portfolios and Specifications
Table 120. Anhui Anke Biotechnology (Group) Human Growth Hormone for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Anhui Anke Biotechnology (Group) Main Business
Table 122. Anhui Anke Biotechnology (Group) Latest Developments
Table 123. Eli Lilly Basic Information, Human Growth Hormone for Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Eli Lilly Human Growth Hormone for Injection Product Portfolios and Specifications
Table 125. Eli Lilly Human Growth Hormone for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Eli Lilly Main Business
Table 127. Eli Lilly Latest Developments
Table 128. Ipsen Basic Information, Human Growth Hormone for Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Ipsen Human Growth Hormone for Injection Product Portfolios and Specifications
Table 130. Ipsen Human Growth Hormone for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Ipsen Main Business
Table 132. Ipsen Latest Developments
Table 133. LG Life Sciences Basic Information, Human Growth Hormone for Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. LG Life Sciences Human Growth Hormone for Injection Product Portfolios and Specifications
Table 135. LG Life Sciences Human Growth Hormone for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. LG Life Sciences Main Business
Table 137. LG Life Sciences Latest Developments
Table 138. Ferring Pharmaceuticals Basic Information, Human Growth Hormone for Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Ferring Pharmaceuticals Human Growth Hormone for Injection Product Portfolios and Specifications
Table 140. Ferring Pharmaceuticals Human Growth Hormone for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Ferring Pharmaceuticals Main Business
Table 142. Ferring Pharmaceuticals Latest Developments
Table 143. Teva Pharmaceutical Industries Basic Information, Human Growth Hormone for Injection Manufacturing Base, Sales Area and Its Competitors
Table 144. Teva Pharmaceutical Industries Human Growth Hormone for Injection Product Portfolios and Specifications
Table 145. Teva Pharmaceutical Industries Human Growth Hormone for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Teva Pharmaceutical Industries Main Business
Table 147. Teva Pharmaceutical Industries Latest Developments
List of Figures
Figure 1. Picture of Human Growth Hormone for Injection
Figure 2. Human Growth Hormone for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Growth Hormone for Injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Human Growth Hormone for Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Human Growth Hormone for Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Water Injection
Figure 10. Product Picture of Powder Injection
Figure 11. Global Human Growth Hormone for Injection Sales Market Share by Type in 2022
Figure 12. Global Human Growth Hormone for Injection Revenue Market Share by Type (2018-2023)
Figure 13. Human Growth Hormone for Injection Consumed in Aldult
Figure 14. Global Human Growth Hormone for Injection Market: Aldult (2018-2023) & (K Units)
Figure 15. Human Growth Hormone for Injection Consumed in Child
Figure 16. Global Human Growth Hormone for Injection Market: Child (2018-2023) & (K Units)
Figure 17. Global Human Growth Hormone for Injection Sales Market Share by Application (2022)
Figure 18. Global Human Growth Hormone for Injection Revenue Market Share by Application in 2022
Figure 19. Human Growth Hormone for Injection Sales Market by Company in 2022 (K Units)
Figure 20. Global Human Growth Hormone for Injection Sales Market Share by Company in 2022
Figure 21. Human Growth Hormone for Injection Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Human Growth Hormone for Injection Revenue Market Share by Company in 2022
Figure 23. Global Human Growth Hormone for Injection Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Human Growth Hormone for Injection Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Human Growth Hormone for Injection Sales 2018-2023 (K Units)
Figure 26. Americas Human Growth Hormone for Injection Revenue 2018-2023 ($ Millions)
Figure 27. APAC Human Growth Hormone for Injection Sales 2018-2023 (K Units)
Figure 28. APAC Human Growth Hormone for Injection Revenue 2018-2023 ($ Millions)
Figure 29. Europe Human Growth Hormone for Injection Sales 2018-2023 (K Units)
Figure 30. Europe Human Growth Hormone for Injection Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Human Growth Hormone for Injection Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Human Growth Hormone for Injection Revenue 2018-2023 ($ Millions)
Figure 33. Americas Human Growth Hormone for Injection Sales Market Share by Country in 2022
Figure 34. Americas Human Growth Hormone for Injection Revenue Market Share by Country in 2022
Figure 35. Americas Human Growth Hormone for Injection Sales Market Share by Type (2018-2023)
Figure 36. Americas Human Growth Hormone for Injection Sales Market Share by Application (2018-2023)
Figure 37. United States Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Human Growth Hormone for Injection Sales Market Share by Region in 2022
Figure 42. APAC Human Growth Hormone for Injection Revenue Market Share by Regions in 2022
Figure 43. APAC Human Growth Hormone for Injection Sales Market Share by Type (2018-2023)
Figure 44. APAC Human Growth Hormone for Injection Sales Market Share by Application (2018-2023)
Figure 45. China Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Human Growth Hormone for Injection Sales Market Share by Country in 2022
Figure 53. Europe Human Growth Hormone for Injection Revenue Market Share by Country in 2022
Figure 54. Europe Human Growth Hormone for Injection Sales Market Share by Type (2018-2023)
Figure 55. Europe Human Growth Hormone for Injection Sales Market Share by Application (2018-2023)
Figure 56. Germany Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Human Growth Hormone for Injection Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Human Growth Hormone for Injection Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Human Growth Hormone for Injection Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Human Growth Hormone for Injection Sales Market Share by Application (2018-2023)
Figure 65. Egypt Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Human Growth Hormone for Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Human Growth Hormone for Injection in 2022
Figure 71. Manufacturing Process Analysis of Human Growth Hormone for Injection
Figure 72. Industry Chain Structure of Human Growth Hormone for Injection
Figure 73. Channels of Distribution
Figure 74. Global Human Growth Hormone for Injection Sales Market Forecast by Region (2024-2029)
Figure 75. Global Human Growth Hormone for Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Human Growth Hormone for Injection Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Human Growth Hormone for Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Human Growth Hormone for Injection Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Human Growth Hormone for Injection Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 注射用ヒト成長ホルモンのグローバル市場予測2023-2029(Global Human Growth Hormone for Injection Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆